BAM Logo

EQAS Therapeutic Drugs Program

EPTIS factsheet 261349 | Last revision 2016-08-05 | URL: https://www.eptis.bam.de/pts261349 https://www.eptis.bam.de/pts261349

PT provider
PT provider Bio-Rad Laboratories, Inc. Bio-Rad Laboratories, Inc.
Based in United States
Language(s) English
Product groups Pharmaceutical products, drugs
Testing fields Analytical chemistry
Medical analysis
Technical details
Test item Tested property Testing method
Lyophilised human serum Therapeutic drugs -
Aims of the PT scheme
Target group of participants Clinical labs worldwide
Linked to specific legislation / standards
Additional, subsidiary aims validation of testing methods
Number of participants 240
Accredited or otherwise reviewed by a 3rd party

Accredited by American Association for Laboratory Accreditation (A2LA) on the basis of ISO 17043:2010


Operation is commissioned / requested by
Fees and frequency
Participation fee
Regularly operated Yes (Monthly)
Year of first operation 1993
Contact details of the PT provider
Provider Contact person
Bio-Rad Laboratories, Inc.
9500 Jeronimo Road
Irvine, CA 92618-2017
United States

Phone: 949-598-1200
Web: http://www.bio-rad.com/eqas http://www.bio-rad.com/eqas
Ms. Azita Mokhtari
Phone: 949-598-1200
Email: eqas_support@bio-rad.com eqas_support@bio-rad.com
If you find any mistakes please contact the responsible EPTIS coordinator in United States, Dr. George W. Latimer, Jr.. Dr. George W. Latimer, Jr..
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5